Abstract
Based on the results of pilot studies from Stiller [2] and Assan [1] four large, placebo-controlled, double-blind studies have recently started in Canada, Europe and the US. The main characteristics of these studies are shown in the Table.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Assan R, Feutren G, Debray-Sachs M, et al. (1985) Metabolic and immunological effects of Cyclosporin in recently diagnosed type 1 diabetes mellitus. Lancet I:67
Stiller CR, Dupré J, Gent M, et al. (1984) Effects of Cyclosporin immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 223:1362
Summary of a Workshop on immunosuppression in the management of type 1 diabetes mellitus (IDD), Diabetes Research Program (1983) National Institute of Health. N Engl J Med 309:1199
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Sandoz Ltd, Basle
About this paper
Cite this paper
von Graffenried, B. (1985). Ciclosporin in Insulin-dependent Diabetes Mellitus: Design of Controlled Studies. In: Schindler, R. (eds) Ciclosporin in Autoimmune Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70607-3_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-70607-3_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-70609-7
Online ISBN: 978-3-642-70607-3
eBook Packages: Springer Book Archive